Specialist Consultation | Asia Immunotherapy | Authority on Immune Cell Therapy - Dr. Yoichi Kato

ASIA IMMUNOTHERAPY is a medical group specializing in cancer immune cell therapy. We work in close collaboration with Japan’s leading immunotherapy authority, Dr. Yoichi Kato, to offer cutting-edge, personalized treatments—including options for late-stage patients.

Specialist Consultation

Fees for Japanese Specialist Consultation

If a patient is interested in exploring immunotherapy options, Asia Immunotherapy can facilitate the submission of medical records to Dr. Yoichi Kato, a leading Japanese specialist, and provide professional Japanese translation services. Dr. Kato will review the reports and, within 7–10 business days, offer an online consultation to discuss potential treatment strategies. The combined fee of HKD 8,000 covers both the review of medical records and the video consultation with Dr. Kato, inclusive of translation costs.


To support patients throughout this journey, our one-stop service encompasses everything from gathering medical reports, arranging online consultations with Dr. Kato, and organizing travel and accommodation, to airport pick-up and professional in-person translation during the treatment process—ensuring a seamless experience. 


Dr. Yoichi Kato

Dr. Yoichi Kato


Dr. Yoichi Kato: Top 5 Specialist in Japan

Dr. Yoichi Kato is a recognized expert in both oncology and gastroenterology, ranked among the top five specialists in Japan by the Japan Association of Advanced Quality Healthcare.

Consultation with Hong Kong Specialists

For patients who prefer to consult a local specialist in Hong Kong, the typical fee for a specialist appointment ranges from HKD 1,500 to HKD 2,000.

Determining the Appropriate Treatment

ASIA IMMUNOTHERAPY will recommend suitable specialists based on each patient’s individual needs. We do not advocate any particular treatment plan on behalf of our company. Instead, treatment decisions are exclusively formulated by the specialist after a thorough evaluation of the patient’s condition.

Go Back